Clinical features and prognosis of cardiac metastatic tumors

BMC Cancer

Table 3 Cardiac ultrasound results before and after cardiac metastasis developed in 8 patients

ID	Status	Cardiac symptoms	Pericardial effusion		Before (mm)									After(mm)
ID	Status	Cardiac symptoms	Pericardial effusion	HR	LAd	LVd	IVSd	PLVWd	LVEF	E/e’	VR	HR	LAd	LVd	IVSd	PLVWd	LVEF	E/e’	VR
1	Died	Yes	No	88	25.0	42.0	11.7	9.5	62	-	-	89	35.0	43.0	11.7	10.7	56	-	+
3	Alive	No	No	63	31.1	35.5	11.6	11.6	60	12.6	-	68	30.0	35.7	10.3	10.5	61	14.1	+
5	Died	Yes	No	87	27.8	42.0	8.4	8.0	63	10.0	+	82	29.2	33.0	9.8	9.5	59	9.4	+
7	Died	No	No	54	32.0	40.0	12.5	14.2	60	-	-	81	33.0	40.0	12.3	14.0	59	-	+
9	Died	Yes	Yes	95	32.7	44.2	10.3	10.1	56	9.1	+	97	32.0	43.3	11.4	10.1	62	12.0	+
26	Died	Yes	Yes	44	36.7	39.9	13.1	10.9	58	10.6	+	79	35.7	40	22.7	14.4	56	12.8	+
34	Died	Yes	Yes	84	32.7	46.9	13.6	11.5	61	8.0	+	127	27.3	37.9	10.3	8.8	59	8.1	+
41	Died	No	No	88	24.0	37.0	13.0	10.7	63	-	+	76	41.2	45.7	12.2	12.3	59	-	+

HR heart rate, Lad left atrial diameter, LVd left ventricular diameter, IVSd interventricular septum diameter, PLVWd left ventricular posterior wall diameter, CO cardiac output, LVEF left ventricular ejection fraction, E/e’ early diastolic transmitral flow velocity/early diastolic mitral annular velocity ratio, VR valvular regurgitation

ISSN: 1471-2407